Wave Life Sciences Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| TAKANASHI KEN | — | Award / Grant | 16,115 | — | — | 5,721,175 | Aug 12, 2024 |
| Vargeese Chandra | See Remarks | Option Exercise | 68,210 | $2.48 | $169,161 | 185,061 | Jul 22, 2024 |
| Moran Kyle | Chief Financial Officer | Sale | 15,630 | $6.17 | $96,437 | 33,921 | Apr 3, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | — | Purchase | 1,000,000 | $5.00 | $5,000,000 | 18,202,009 | Dec 11, 2023 |
| Kolchinsky Peter | — | Purchase | 1,000,000 | $5.00 | $5,000,000 | 19,202,009 | Dec 11, 2023 |
| GSK plc | — | Purchase | 3,300,000 | $5.00 | $16,500,000 | 13,983,761 | Dec 7, 2023 |
| Moran Kyle | Chief Financial Officer | Sale | 37,062 | $4.75 | $176,045 | 46,120 | Aug 23, 2023 |
| Vargeese Chandra | See Remarks | Sale | 10,249 | $4.03 | $41,303 | 106,624 | Feb 16, 2023 |
| BOLNO PAUL | President and CEO | Sale | 29,400 | $4.04 | $118,776 | 407,425 | Feb 16, 2023 |
| Francis Chris | See Remarks | Sale | 10,258 | $4.03 | $41,340 | 79,714 | Feb 16, 2023 |
| Moran Kyle | Chief Financial Officer | Sale | 9,729 | $4.04 | $39,305 | 79,751 | Feb 16, 2023 |
| RA Capital Healthcare Fund LP | — | Purchase | 9,480,052 | $2.15 | $20,382,112 | 17,202,009 | Jun 16, 2022 |
| BOLNO PAUL | President and CEO | Award / Grant | 92,500 | — | — | 470,326 | May 5, 2022 |
| Panzara Michael A. | See Remarks | Award / Grant | 50,000 | — | — | 125,817 | May 5, 2022 |
| Francis Chris | See Remarks | Award / Grant | 32,500 | — | — | 100,839 | May 5, 2022 |
| Vargeese Chandra | See Remarks | Sale | 16,714 | $1.72 | $28,748 | 111,095 | May 4, 2022 |
| Moran Kyle | Chief Financial Officer | Sale | 5,021 | $1.72 | $8,636 | 84,567 | May 4, 2022 |
| Moran Kyle | Chief Financial Officer | Sale | 9,204 | $2.31 | $21,261 | 74,588 | Feb 16, 2022 |
| Francis Chris | See Remarks | Sale | 10,123 | $2.31 | $23,384 | 68,339 | Feb 16, 2022 |
| Vargeese Chandra | Chief Technology Officer | Sale | 10,603 | $2.32 | $24,599 | 77,809 | Feb 16, 2022 |
| BOLNO PAUL | President and CEO | Sale | 33,150 | $2.32 | $76,908 | 377,826 | Feb 16, 2022 |
| Panzara Michael A. | See Remarks | Sale | 10,603 | $2.31 | $24,493 | 75,817 | Feb 16, 2022 |
| Kolchinsky Peter | — | Other | 201,594 | $5.61 | $1,130,942 | 201,594 | Apr 1, 2021 |
| Moran Kyle | Chief Financial Officer | Option Exercise | 10,930 | $2.48 | $27,106 | 80,792 | Mar 24, 2021 |
| Moran Kyle | Chief Financial Officer | Award / Grant | 50,000 | — | — | 71,584 | Feb 16, 2021 |
| Francis Chris | See Remarks | Sale | 2,698 | $10.57 | $28,518 | 78,462 | Feb 1, 2021 |
| BOLNO PAUL | President and CEO | Sale | 11,205 | $10.57 | $118,437 | 410,976 | Feb 1, 2021 |
| Panzara Michael A. | See Remarks | Sale | 2,929 | $10.57 | $30,960 | 86,420 | Feb 1, 2021 |
| Vargeese Chandra | Chief Technology Officer | Sale | 3,145 | $10.57 | $33,243 | 85,412 | Feb 1, 2021 |
| BOLNO PAUL | President and CEO | Sale | 100,000 | $15.00 | $1,500,000 | 272,181 | Sep 15, 2020 |
| BOLNO PAUL | President and CEO | Option Exercise | 25,000 | $2.48 | $62,000 | 297,181 | Aug 25, 2020 |
| BOLNO PAUL | President and CEO | Option Exercise | 100,000 | $2.48 | $248,000 | 372,181 | Jul 2, 2020 |
| Panzara Michael A. | Chief Medical Officer | Sale | 2,981 | $7.85 | $23,401 | 39,349 | Feb 18, 2020 |
| BOLNO PAUL | President and CEO | Sale | 11,451 | $7.85 | $89,890 | 319,758 | Feb 18, 2020 |
| Francis Chris | See Remarks | Sale | 2,708 | $7.85 | $21,258 | 31,160 | Feb 18, 2020 |
| Vargeese Chandra | Senior VP, Drug Discovery | Sale | 3,188 | $7.85 | $25,026 | 37,057 | Feb 18, 2020 |
| Gaiero David G | Interim CFO | Sale | 651 | $7.00 | $4,557 | 6,392 | Feb 3, 2020 |
| Vargeese Chandra | Senior VP, Drug Discovery | Sale | 6,000 | $35.00 | $210,000 | 40,245 | Dec 3, 2019 |
| Verdine Gregory L. | — | Sale | 2,609 | $32.74 | $85,419 | 30,000 | Nov 20, 2019 |
| Baldry Mark | Chief Commerical Officer | Award / Grant | 4,000 | — | — | 39,000 | Aug 5, 2019 |
| Panzara Michael A. | Chief Medical Officer | Sale | 2,613 | $26.88 | $70,237 | 42,775 | Jul 5, 2019 |
| BOLNO PAUL | President and CEO | Option Exercise | 50,000 | $2.48 | $124,000 | 381,209 | Mar 15, 2019 |
| Panzara Michael A. | Franchise Lead, Neurology | Award / Grant | 15,000 | — | — | 52,388 | Mar 11, 2019 |
| Regnante Keith | Chief Financial Officer | Award / Grant | 13,500 | — | — | 29,186 | Mar 7, 2019 |
| BOLNO PAUL | President and CEO | Award / Grant | 60,000 | — | — | 331,209 | Mar 7, 2019 |
| Francis Chris | See Remarks | Award / Grant | 13,500 | — | — | 33,868 | Mar 7, 2019 |
| Vargeese Chandra | Senior VP, Drug Discovery | Award / Grant | 15,000 | — | — | 40,245 | Mar 7, 2019 |
| Regnante Keith | Chief Financial Officer | Sale | 1,298 | $36.84 | $47,818 | 15,686 | Feb 19, 2019 |
| Panzara Michael A. | Franchise Lead, Neurology | Sale | 1,837 | $36.84 | $67,675 | 37,388 | Feb 19, 2019 |
| BOLNO PAUL | President and CEO | Sale | 7,614 | $36.38 | $276,997 | 271,328 | Feb 19, 2019 |